Evidence map›Paper›PMID 32042667›Full record

ArticleGland surgery2019

A novel, adaptable, radiographically opaque, multi-plane continuous filament marker for optimizing tissue identification, radiation planning, and radiographic follow-up.

Sunny Mitchell, Henry Lee, Beth Baughman DuPree, David C Beyer, Michael Ulissey, Stephen R Grobmyer, Jennifer Gass, Susan Boolbol, Toni Storm-Dickerson

Open access · diamondAbstract read
In one paragraph

Article in Gland surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Sunny MitchellDepartment of Surgery, Montefiore Nyack Hospital, Nyack, NY, USA.
Henry LeeDepartment of Radiation Oncology; New York Presbyterian-Lawrence Hospital, Columbia University College of Physicians & Surgeons, Bronxville, NY, USA.
Beth Baughman DuPreeSedona Breast care, Department of Surgery, Cancer Centers of Northern Arizona Healthcare, Sedona, AZ, USA.
David C BeyerDepartment of Radiation Oncology, Cancer Centers of Northern Arizona Healthcare, Sedona, AZ, USA.
Michael UlisseyDepartment of Radiology, The University of Texas Health Sciences Center, San Antonio, TX, USA.
Stephen R GrobmyerOncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Jennifer GassDepartment of Surgery, Women & Infants Hospital, Brown University, Providence, RI, USA.
Susan BoolbolDepartment of Surgery, Mount Sinai Beth Israel, Icahn School of Medicine, New York, NY, USA.
Toni Storm-DickersonDepartment of Surgery, Kearney Breast Center, Vancouver, WA, USA.
Columbia University · USMount Sinai Beth Israel · USNyack Hospital · USThe University of Texas Health Science Center at San Antonio · USWomen & Infants Hospital of Rhode Island · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn breast cancer treatment, marking the tumor bed is an important aspect of the surgical component of therapy. Clear delineation of the tumor bed allows radiation oncologists a defined target for planning and delivering postoperative radiation therapy (XRT). Tumor bed marking also allows radiographic follow-up of the tumor bed on subsequent breast imaging. The aim of this assessment is to evaluate the ease and feasibility of utilizing a tumor bed filament marker (VeraFormÒ, Videra Surgical inc., USA) as a marker in post-operative benign surgical sites and malignant breast surgical tumor beds in breast cancer surgery.

methodsThe filament marker is a novel radiopaque surgical filament that in lieu of clips and other markers is implanted in the surgical tumor bed during breast surgery. Following development of the filament marker, the researchers used breast phantoms and radiographic images to develop a series of geometric patterns of placement options that optimize comprehensive multi-plane radiographic interpretation of the exact tumor bed or surgical margin. Three breast surgeons at 3 separate institutions then used this filament as a continuous multi-plane marker in 20 patients during breast conservation surgery. In these patients, the filament marker was thus used to mark the tumor bed (breast cancer surgery) or surgical site (benign breast disease) instead of the more traditional devices such as clips or other metallic open framework devices. We then assessed 2 important factors related to this device; (I) the ease, feasibility, and accuracy of

resultsThere were no adverse events reported with the use of this device. The cases were then reviewed by a multidisciplinary team that included the original surgeon, a breast radiologist, and radiation oncologist. Their unanimous evaluation was that the filament marker clearly delineated all sides and planes of the tumor bed (cancer surgery) or surgical site (benign disease). Regardless of surgical technique utilized, this information provided precise 3D guidance for radiation planning and delivery as well as radiographic follow-up. The surgeons involved reported that delineating the bed with the filament marker was a quick and easy procedure and did not interfere with performing the planned surgical technique. Radiologists, surgeons, and radiation oncologists found that the filament marker was not only radiographically opaque on CT and MMG, but also caused no significant artifact on CT, MRI, US, or MMG.

conclusionsThe continuous multi-plane filament marker is a new device that fulfills the heretofore unmet need for safe and improved tumor bed and tissue site marking. It is an easy to place, non-palpable continuous multi-plane radiographic opaque tissue marker that seems to better delineate the tumor bed, regardless of type of breast surgery performed, while providing a more accurate 3D image for radiation planning and radiographic follow-up on MMG MRI, CT and US.

Indexed as

Breast cancerbreast surgeryfilament markeroncoplasticradiation planningtumor bed marker

Identifiers

PMID32042667
PMCPMC6989892
OpenAlexW2985464939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.